NCT06826313View on ClinicalTrials.gov

A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 19, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

March 1, 2027

Conditions
Solid Tumors
Interventions
BIOLOGICAL

VRT106

Intravenous drip administration

Trial Locations (1)

510000

RECRUITING

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

Sponsors
All Listed Sponsors
collaborator

Third Affiliated Hospital, Sun Yat-Sen University

OTHER

lead

Guangzhou Virotech Pharmaceutical Co., Ltd.

INDUSTRY

NCT06826313 - A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter